MRTNZ

MRTNZ Investment Office · S&P 500 · The 360 Vantage

WAT · NYSE

Waters Corporation

Industrials · Biotechnology: Laboratory Analytical Instruments

Reference price$383.90As of Jul 28, 2026
Market capitalization$37.69B
52-week range$275.05–$414.15
S&P 500 portfolio weight0.06%
Data qualitycomplete

Street view

Analyst targets

Published sell-side aggregation—not an MRTNZ forecast.

Low$350.00-8.8% vs. reference
Average$403.33+5.1% vs. reference
High$440.00+14.6% vs. reference
10 Buy9 Hold0 Sell

Forward calendar

Current earnings expectations

Consensus may change until the company reports.

Expected reportAug 4, 2026Jun 2026
Consensus EPS$3.017 estimates
Expected range$2.98–$3.04Low to high EPS
Dec 2026$14.51Street EPS consensus
Dec 2027$16.54Street EPS consensus
Dec 2028$18.72Street EPS consensus

Reported results

Annual financial snapshot

Fiscal period ended Dec 31, 2025.

MetricCurrentPrior
Revenue+7.0% YoY$3.17B$2.96B
Operating income$0.8B$0.83B
Net income$0.64B$0.64B
Operating cash flow$0.65B$0.76B
Capital expenditures($0.11B)($0.14B)

Current context

Related news

Company-linked articles surfaced by Nasdaq.

Zacks

Waters (WAT) Earnings Expected to Grow: Should You Buy?

Zacks

Will Waters (WAT) Beat Estimates Again in Its Next Earnings Report?

Zacks

IQVIA Gears Up to Report Q2 Earnings: What's in the Offing?

Evidence

Sources & method

Nasdaq quote →Nasdaq summary →Earnings forecast →Annual financials →Official S&P 500-tracking holdings →

Facts, estimates, and scenarios are kept separate. Analyst targets and EPS expectations are third-party estimates, not MRTNZ forecasts. Index weight uses the official IVV portfolio as the denominator. Illustrative research, not investment advice.